Stimulant drug effects in developmental disorders and hyperactivity--toward a resolution of disparate findings.
Stimulants help only when the child’s attention profile matches the ADHD pattern, so test and watch closely.
01Research in Context
What this study did
Murphy (1982) wrote a long think-piece, not a lab study. He pulled together early trials on stimulant pills for kids with autism, intellectual disability, ADHD, and typical kids.
He asked why speed-up drugs help ADHD and typical children but usually flop for kids with autism or low IQ.
What they found
The paper says the drugs fail because attention works differently. Kids with autism use narrow, steady focus. ADHD kids use fast, flexible focus.
Same pill, different wiring, different outcome.
How this fits with other research
Rimmer et al. (1995) ran the first real test. They gave methylphenidate to autistic kids. Hyperactivity dropped a little and stereotypy did not rise. The result trims G’s blanket “it fails” claim.
Patra et al. (2019) updated the story for atomoxetine. Their meta-analysis shows modest parent-rated gains for ADHD symptoms in autistic kids. The attention model still matters, but the “no benefit” line is now softer.
Hudson et al. (2012) zoom out. Their big systematic review says only a few pills have solid proof in autism. G’s early warning fits inside their larger map of weak evidence.
Why it matters
Before you trial a stimulant, map the child’s attention style. Quick-switch kids may respond; single-track kids may not. Use small test doses, track hyperactivity and stereotypy, and lean on later reviews like Hudson et al. (2012) for evidence checks.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Plot the child’s attention shifts during a 10-minute play task; share the pattern with the prescriber before trialing any stimulant.
02At a glance
03Original abstract
An attempt is made to integrate data from a variety of clinical populations and from the animal literature. Evidence is presented suggesting that mentally retarded and autistic children generally show a poor response to stimulant medication, whereas hyperactive and normal children respond beneficially. Cognitive research in mentally retarded and autistic children is reviewed, and it is suggested that both diagnostic groups suffer from attentional difficulties, the mechanisms of which may be very similar. The literature on stimulant-induced stereotypy in animals is discussed, with emphasis on the clinical implications for autism and mental retardation. An attentional model is proposed to account for type of therapeutic response to stimulant medication. This is followed by a possible method for testing the model and by specific predictions relating to subject characteristics and response.
Journal of autism and developmental disorders, 1982 · doi:10.1007/BF01538326